23099-21-0 Usage
General Description
3-Aminomethyl-piperidine is an organic compound that belongs to the class of piperidines, which are six-membered heterocycles containing one nitrogen atom. It is an amine derivative with a piperidine backbone and a primary amino group, making it a versatile building block for the synthesis of various pharmaceuticals and agrochemicals. This chemical has been studied for its potential applications in the development of new drugs, including antipsychotics, antidepressants, and analgesics. It is also utilized as a reagent in organic synthesis and as an intermediate in the production of other chemicals. 3-Aminomethyl-piperidine is an important compound in the field of medicinal chemistry and drug discovery due to its unique chemical properties and potential biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 23099-21-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,0,9 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 23099-21:
(7*2)+(6*3)+(5*0)+(4*9)+(3*9)+(2*2)+(1*1)=100
100 % 10 = 0
So 23099-21-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H14N2/c7-4-6-2-1-3-8-5-6/h6,8H,1-5,7H2
23099-21-0Relevant articles and documents
CANCER TREATMENTS TARGETING CANCER STEM CELLS
-
Paragraph 0331; 0428-0430, (2019/11/19)
Disclosed are compounds, methods, compositions, and kits that allow for treating cancer by, e.g., targeting cancer stem cells. In some embodiments, the cancer is colorectal cancer, gastric cancer, gastrointestinal stromal tumor, ovarian cancer, lung cancer, breast cancer, pancreatic cancer, prostate cancer, testicular cancer, or lymphoma. In some embodiments, the cancer is liver cancer, endometrial cancer, leukemia, or multiple myeloma. The compounds utilized in the disclosure are of Formula (0), (O'), and (I):
Pyrimido[5,4]-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof
-
, (2008/06/13)
Pyrimido[5,4-d]pyrimidines of the general formula [Figure] which have an inhibitory effect on signal transduction mediated by tyrosine kinases, their use for the treatment of disorders, in particular of oncoses, and their preparation. Exemplary compounds are: 4-[(3-Chloro-4-fluorophenyl)amino]-6-[1-methyl-4-piperidinylamino]pyrimido[5,4-d]pyrimidine, and 4-[(3-Chloro-4-fluorophenyl)amino]-6-[trans-4-dimethyl-aminocycohexylamino]pyrimido[5,4-d]pyrimidine.
